Low-molecular-weight heparin protects kidney through an anti-apoptotic mechanism in a rat pre-eclamptic model

European Journal of Obstetrics, Gynecology, and Reproductive Biology
Yuan ZhangMei Zhong

Abstract

To investigate the effect of low-molecular-weight heparin (LMWH) for the treatment of pre-eclampsia (PE) and the underlying mechanism. PE was established in a rat model using l-NG-nitroarginine methyl ester (l-NAME). The effect of LMWH was examined by measuring various physiological parameters known to be associated with PE. Blood pressure, urinary protein, blood urea nitrogen and serum creatinine were higher in l-NAME-treated rats compared with control rats. In addition, the number of fetuses, and the weight of fetuses and placentas was lower in l-NAME-treated rats, indicating the establishment of PE conditions. Apoptosis was found in kidney tissue in l-NAME-treated rats. LMWH treatment restored the PE-associated disorders, and inhibited apoptosis in kidney tissue in these rats. LMWH can control PE conditions, protect renal function and improve fetal health. The mechanism of renal protection is likely to be related to the inhibitory effect of LMWH on apoptosis in kidney tissue. This study provides evidence that LMWH can potentially be used as a safe and effective anti-PE drug to improve PE conditions and protect renal function by inhibiting PE-induced apoptosis.

References

Jan 1, 1996·British Journal of Obstetrics and Gynaecology·N H MorrisG Dekker
Apr 14, 2000·American Journal of Obstetrics and Gynecology·M de Swiet
May 12, 2001·American Journal of Obstetrics and Gynecology·D N LeungP N Baker
Oct 11, 2001·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·P López-JaramilloN Serrano
Jul 10, 2003·Obstetrics and Gynecology·Baha M Sibai
Apr 4, 2006·Lancet·Khalid S KhanPaul Fa Van Look
May 26, 2006·American Journal of Obstetrics and Gynecology·Brian J CoatesCynthia A Standley
Jul 27, 2006·Hypertension in Pregnancy : Official Journal of the International Society for the Study of Hypertension in Pregnancy·Jessica J Vanderlelie, Anthony V Perkins
Jan 7, 2009·Therapeutic Advances in Cardiovascular Disease·Patricio López-JaramilloMarcos López
Jul 1, 2009·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Aurélie RousseauPatrick Van Dreden
Nov 17, 2009·Journal of Thrombosis and Haemostasis : JTH·S ManthaJ I Zwicker
Dec 3, 2009·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Yan-Hong YuShi-Peng Gong
Nov 30, 2011·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Valentina ConservaEnrico Ferrazzi

❮ Previous
Next ❯

Citations

Mar 21, 2020·American Journal of Physiology. Heart and Circulatory Physiology·Kelsey McLaughlinJohn C Kingdom
Apr 7, 2020·Hypertension·Kathryn L GatfordAlison S Care
Dec 15, 2016·Frontiers in Medicine·Douglas B Kell, Louise C Kenny

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aphasia

Aphasia affects the ability to process language, including formulation and comprehension of language and speech, as well as the ability to read or write. Here is the latest research on aphasia.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

© 2021 Meta ULC. All rights reserved